It has been observed that the lack of an MCH or MCH1 receptor could have anti-obesity effects; therefore, it has been suggested as a potential target in obesity and NAFLD (49). The gene discussed is PMCH; the disease is metabolic dysfunction-associated steatotic liver disease.